Sep 2026· Small Methods· pp.
e71034
· 0 citations· 37 references
Medicine
TL;DR
A simplified, reliable and cost-effective extraction platform based on iron oxide nanoparticles synthesized via coprecipitation provides a foundation for accessible, potentially at-home cfDNA extraction and advances the development of truly non-invasive diagnostic strategies for longitudinal disease monitoring and management.
Abstract
Urinary cell-free DNA (cfDNA) is a promising substrate for non-invasive liquid biopsy analysis and biomarker detection. However, the lack of standardized pre-analytical workflows and the intrinsic challenges associated with isolating highly dilute and fragmented cfDNA limit its broader research and clinical applications. Here, we present a simplified, reliable and cost-effective extraction platform based on iron oxide nanoparticles (IONPs) synthesized via coprecipitation. By leveraging nature-inspired surface functionalization, these magnetic nanoparticles enable the rapid and direct isolation of cfDNA from fresh urine while supporting scale-up of the processing volumes. The proposed platform achieves a 2-fold increase in cfDNA yield compared to conventional commercial extraction kits and demonstrates enhanced recovery of short DNA fragments, with a predominant size distribution between 80-150 bp. This improved capture efficiency facilitates a detection sensitivity down to 10-3 ng/mL using qPCR, likely limited by assay sensitivity rather than DNA extraction performance. Moreover, the simplified extraction and elution steps eliminate the need for specialized laboratory instrumentation. Collectively, this approach provides a foundation for accessible, potentially at-home cfDNA extraction and advances the development of truly non-invasive diagnostic strategies for longitudinal disease monitoring and management.
Cell-free DNA (cfDNA), released from apoptotic and necrotic cells into body fluids, is a non-invasive source of genetic information for disease prediction, diagnosis, and monitoring. However, its low abundance makes cfDNA highly susceptible to various pre-analytical influences, potentially increasing high molecular wei...
M. Apweiler, J. Broche, M. Loitz et al.· Journal of Molecular Diagnos...· 0 citations
The MIRACLE platform is developed, an integrated system combining microfluidic magneto-controllable reversible affinity capture with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for efficient, multiplexed detection of tumor-derived EV DNA mutations.
Early screening of many types of cancers remains limited by the invasiveness of gold-standard tissue biopsies and the poor specificity of traditional clinical biomarkers like prostate-specific antigen (PSA). Non-invasive liquid biopsies are the emerging alternatives. Urine is one of the preferred body fluids for liquid...
Eleni Lamprou, Dimitrios Papakyriakou, D. Kalogianni· Italian National Conference...· 0 citations
Urine is an attractive source of tumor-derived DNA because collection is non-invasive, repeatable, and compatible with large-volume or home-based sampling. Urinary DNA comprises biologically distinct fractions, principally cellular DNA from exfoliated cells and urinary cell-free DNA (cfDNA), which may originate from lo...
Bogdan-Petru Tichil, Anamaria Besleaga, Mihaela Laura Vică Matei et al.· Journal of Clinical Medicine· 0 citations
Liquid biopsies enhance early cancer detection by enabling “multiomic” interrogation of several analyte classes simultaneously. For optimal performance, blood collection tubes (BCTs) must preserve these analytes closely to their in vivo state. Many BCTs use formaldehyde-based fixation to preserve cellular structu...
Zhong-Yue Luan, K. Kwan, Aurora Horta et al.· Clinical Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.